University of North Carolina

Exemplifying their commitment to linking statewide resources in the biosciences, The Hamner Institutes and The University of North Carolina at Chapel Hill (UNC) have jointly created a unique integrative model that will guide innovative collaborations in basic and translational research. 

Established with the UNC schools of medicine, pharmacy and public health, and its Kenan-Flagler Business School, this unique partnership capitalizes on the scientific strengths of a leading university and an independent research institute, both of which are committed to accelerating advances in human therapeutics and public health locally and internationally.

The scientific and business development teams at The Hamner Institutes work closely with UNC faculty, including those from the Center for Integrative Chemical Biology and Drug Discovery in the Schools of Pharmacy, Medicine and College of Arts and Sciences, UNC Kenan-Flagler Business School and the University’s Office of Technology Development to identify, assess and enhance development of new research leads. They collaboratively pursue a wide array of research grant opportunities from government, industry and non-profit organizations to accelerate development of promising research and technologies that can be licensed out and/or spun out into the University’s new innovation center.

The partnership between The Hamner Institutes and the University has created The Hamner-University of North Carolina Institute for Drug Safety Sciences.  This collaboration also draws upon extensive resources available at the state’s other academic institutions and the North Carolina Biotechnology Center, which supports statewide faculty recruitment, scientific education, economic development and technology development.

Together, The Hamner and The University of North Carolina at Chapel Hill are dedicated to improving human health, while also yielding new economic opportunities for North Carolinians.